NAD-boosting may stabilise telomeres to slow aging

Latest articles

Ovarian aging – it’s time to menopause for thought

It's World Menopause Day – time to focus on the future of ovarian longevity, not dwell in the present. World Menopause Day is held every...

At-home blood test powers personalised longevity advice

AgeRate develops proprietary DNA methylation clock and mobile app solution to offer users personalised longevity support. Canadian startup AgeRate is aiming to shake up the...

Researchers find warning signs for dementia in the blood

Levels of certain microRNAs indicate risk for cognitive decline. Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the...

VIDEO: The Science of Ovarian Longevity

Instead of papering over the cracks of declining fertility and the effects of menopause, what else can we do to help the longevity of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Ovarian aging – it’s time to menopause for thought

It's World Menopause Day – time to focus on the future of ovarian longevity, not dwell in the present. World Menopause Day is held every...

At-home blood test powers personalised longevity advice

AgeRate develops proprietary DNA methylation clock and mobile app solution to offer users personalised longevity support. Canadian startup AgeRate is aiming to shake up the...

Researchers find warning signs for dementia in the blood

Levels of certain microRNAs indicate risk for cognitive decline. Researchers at the DZNE and the University Medical Center Göttingen (UMG) have identified molecules in the...

Click the globe for translations.

A recent study shows that nicotinamide riboside helps alleviate telomere dysfunction in human cells.

The length of telomeres decreases with age, and telomere dysfunction has been associated with many age-related pathologies. Although the importance of telomeres in cellular senescence and aging has been known for years, little success has been made in translating this knowledge into interventions to prevent aging and treat age-related diseases [1].

Longevity.Technology: Recently, scientists from the National Institute on Aging/National Institutes of Health (NIH) found that restoring homeostasis in NAD metabolism using nicotinamide riboside alleviates telomere dysfunction, promoting genomic stability. Given the role of telomere dysfunction in cellular senescence, this discovery may have important implications for the treatment of age-related disorders. The study was led by Dr Yie Liu and was published in September 2020 in The EMBO Journal [2].

Telomeres are repetitive DNA sequences acting as protective caps of chromosomes. Because they are found at the ends of chromosomes, telomeres shorten every time a cell proliferates. The loss of telomeres, also known as telomere dysfunction, can lead to senescence or cell death, ensuring that cells can only divide for a limited number of times. Given the strong links between telomeres and senescence, it is not surprising that telomere dysfunction is a common feature of the premature aging disorder dyskeratosis congenita and other age-related diseases.

 


 

“Telomere attrition is recognized as one of the nine hallmarks of aging, and it is well accepted that telomeres play a significant role in aging and many age-related health declines. These preliminary results suggest that NR can impact telomere function.”

 


 

 

The research team of Dr Yie Liu showed that fibroblasts with telomere dysfunction exhibit reduced levels of nicotinamide adenine dinucleotide (NAD), a key cellular metabolite whose levels naturally decline with age. This disruption in NAD levels affected several cellular metabolic pathways by increasing CD38 activity and decreasing poly(ADP‐ribose) polymerase and SIRT1 activities. They confirmed these findings in fibroblasts from patients with dyskeratosis congenita and mice lacking telomerase – the enzyme that extends telomeres.

Interestingly, the scientists demonstrated that supplementation with the NAD precursor nicotinamide riboside alleviated telomere dysfunction by restoring NAD homeostasis. Importantly, the alleviation of telomere damage in fibroblasts from dyskeratosis congenita patients restored mitochondrial function, cell growth, and cellular senescence – all of which are hallmarks of aging.

Phase 2 study finds addition of nutritional protocol to standard of care reduces recovery time in mild-to-moderate COVID-19 patients.

ChromaDex Inc., a science-driven nutraceutical company, has supported the study by providing NIH researchers with nicotinamide riboside for the  ChromaDex External Research Program (CERP). Through this programme, ChromaDex collaborates with universities and research institutes worldwide to explore the potential of NAD to extend lifespan and healthspan.

“Telomere attrition is recognized as one of the nine hallmarks of aging, and it is well accepted that telomeres play a significant role in aging and many age-related health declines,” said Frank Jaksch, Co-Founder & Executive Chairman of ChromaDex [3]. “These preliminary results suggest that NR can impact telomere function.”

ChromaDex has invested over $35 million in exploring the therapeutic effects of nicotinamide riboside (licensed as TRU NIAGEN), for which ChromaDex holds over 20 patents. The company has already demonstrated the safety and efficacy of NIAGEN in humans and has secured regulatory approval in the USA, Canada, the EU and Australia for its use as a health supplement.

These findings reveal a direct link between telomere shortening and NAD metabolism and highlight the importance of NAD dysregulation in the aging-promoting effects of telomere dysfunction. The usefulness of interventions restoring NAD homeostasis in treating dyskeratosis congenita and other telomere‐driven disorders is currently under clinical investigation.

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342515/
[2] https://www.embopress.org/doi/full/10.15252/embj.2019103420
[3] https://bit.ly/3mulljR

Images courtesy of ChromaDex
Christos Evangelou
Since the completion of his undergraduate and doctoral studies in Molecular Biosciences, Christos has been working in the medical communications industry, driven by his passion for communicating sciences. Apart from helping researchers to publish their studies, Christos writes articles related to sciences and medicine.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

A new approach to reversing tissue aging

Exploring Revel’s enzyme-based approach to breaking down crosslinks and targeting tissue aging. Last year, a startup called Revel Pharmaceuticals emerged from the labs at Yale...

Ovarian aging – your questions answered

Ovarian longevity and the significance of ovarian aging is poorly understood – our video aims to change that. Join our Scientific Editor Daragh Campbell as...

Learning lessons from clinical trial failure

Metabesity 2021: Joan Mannick talks longevity scientific breakthroughs, healthspan endpoints, her new role at Life Biosciences, and what can be learned from resTORbio’s clinical...

Ovarian aging – what women aren’t told about their health

Ovaries set the pace for aging and changing that pace could be the key to improving fertility, healthspan and lifespan. Words like fertility, menstruation, menopause,...

Wyss Institute receives organ-on-a-chip funding boost

The award will fund the development of human Organ Chips with automated in-line sensors to study vaccine responses. Harvard's Wyss Institute for Biologically Inspired Engineering...